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FRET Detection of Calmodulin Binding and Structural Rearrangements
Within the Cardiac RyR2 Calcium Release Channel
Bradley R. Fruen, Mallory Turner, Florentin R. Nitu, David D. Thomas,
Razvan L. Cornea.
University of Minnesota, Minneapolis, MN, USA.
Calmodulin (CaM) binds to a conserved domain of the ryanodine receptor iso-
forms expressed in skeletal muscle (RyR1) and cardiac muscle (RyR2) to evoke
isoform-specific changes in channel gating. To better understand CaM’s inter-
actions with the RyR2 isoform, we are using fluorescence resonance energy
transfer (FRET) to define the orientation and kinetics of CaM binding, and to
resolve structural rearrangements linked to channel regulation. A FRET donor
was targeted to the RyR2 cytoplasmic assembly by preincubating cardiac sar-
coplasmic reticulum membranes with a fluorescent-labeled FKBP12.6
(F-FKBP). An acceptor fluorophore was attached within the N-lobe of CaM
(F-CaM). A decrease in F-FKBP fluorescence upon addition of F-CaM pro-
vided a specific, real-time readout of CaM binding to the RyR2, despite the
presence of additional non-RyR CaM targets in the cardiac membranes.
FRET demonstrated that the affinity of F-CaM binding to RyR2 was greater
in 100 mM than in 30 nM Ca2þ. The maximal FRET observed in the presence
of saturating [F-CaM] increased as a function of [Ca2þ] (30 nM to 1 mM). The
Ca2þ dependence of this increase in FRET was similar to the Ca2þ dependence
of [3H]ryanodine binding to RyR2 assayed in equivalent media (KCa ~5 mM).
A marked decrease in FRET between FKBP12.6 and CaM was observed
when the acceptor was shifted from CaM’s N-lobe to CaM’s C-lobe. We con-
clude that CaM binds to the RyR2 in an extended conformation, with its N-lobe
oriented nearest to the FKBP12.6 subunit. CaM’s conformation and orientation
when bound to the RyR2 are therefore similar to what has been demonstrated
previously for the RyR1 isoform (Cornea et al., 2009). Ca2þ dependent changes
in FRET between FKBP12.6 and CaMmay reflect structural changes within the
RyR2 linked to channel activation by Ca2þ.
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Localization of Potential Calmodulin Binding Sequences onto the Three
Dimensional Structure of the Cardiac Ryanodine Receptor Reveals A
Binding Pocket for Calmodulin
Xiaojun Huang1, Ruiwu Wang2, Andrea Koop2, S.R. Wayne Chen2,
Terence Wagenknecht1, Zheng Liu1.
1Wadsworth Center, Albany, NY, USA, 2University of Calgary, Calgary, AB,
Canada.
Calmodulin (CaM), a 16 kDa ubiquitous calcium-sensing protein, is known to
bind tightly to the cardiac calcium release channel/ryanodine receptor (RyR2)
at low and high Ca2þ concentrations, and modulate the function of the channel.
CaM binding studies using RyR fragments or synthetic peptides have revealed
that multiple regions in the RyR’s primary sequence may be involved in CaM
binding. However, the locations of these potential CaM binding regions in the
three dimensional structure of RyRs have yet to be determined. In the present
study, we inserted GFP or GST into these proposed CaM binding sequences and
mapped some of them onto the three-dimensional structure of intact RyR2 by
cryo-electron microscopy and single particle image analysis. Surprisingly, we
found that some of these potential CaM binding regions, e.g. Arg-3595 and
Lys-4269, are located in close proximity and are adjacent to the CaM binding
sites that were mapped previously by 3D cryo-EM. These observations suggest
that multiple regions in the RyR2 sequence may form a binding pocket for
CaM. (Supported by NIH and CIHR).
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Ryanodine Receptor Channels are Regulated by Specific Binding of A
Membrane Phospholipid Metabolite
Akira Uehara.
Fukuoka Univ, Fukuoka, Japan.
Sphingosylphosphatidylcholine (SPC) is metabolized from sphingomyelin
(SM) of a minor cell membrane phospholipid during the apoptosis and the hy-
perlipidemia. Lysophosphatidylcholine (LPC) is produced from phosphatidyl-
choline (PC) of a major membrane phospholipid during the ischemia. These
lipid metabolites are known to modify a variety of ion channels. In the present
study, we examined in detail with the planar lipid bilayer method how the car-
diac RyR channels are modified by SPC and LPC. The cis-side addition of SPC
blocked the channels at the mM level, while the trans-side addition of SPC did
not affect. SPC hardly change the membrane capacitance. A kinetic model held
in the SPC effect. SPC could thus exert a specific effect via its binding to the
cytoplasmic domain of the RyR molecule. On the other hand, both cis-side
and trans-side additions of LPC activated the RyR channels at the mM level.
LPC significantly increased the membrane capacitance. No kinetic model
held in the LPC effect. Unlike SPC, LPC could thus exert a nonspecific indirect
effect on the RyR channel via a fusion of LPC into the membrane lipids.1570-Pos
Molecular Determinants of Ca2þ Release Termination in the Cardiac Rya-
nodine Receptor
Xixi Tian, Yijun Tang, Ruiwu Wang, Wenqian Chen, S.R. Wayne Chen.
University of Calgary, Calgary, AB, Canada.
A longstanding question in the field of excitation-contraction coupling in car-
diac muscle is how Ca2þ release from the sarcoplasmic reticulum (SR) is ter-
minated. Recent studies have suggested that SR Ca2þ release terminates as a re-
sult of luminal Ca2þ dependent inactivation of the Ca2þ release channel/
ryanodine receptor (RyR2). However, the molecular basis of luminal Ca2þ de-
pendent inactivation of RyR2 is unknown. We have previously shown that the
pore region of RyR2 is critical for the initiation of spontaneous Ca2þ release or
store overload induced Ca2þ release (SOICR). In the present study, we deter-
mined whether the pore region of RyR2 is also important for Ca2þ release ter-
mination. To this end, we mutated each residue within the inner helix and the
helix bundle crossing, and generated stable, inducible HEK293 cell lines ex-
pressing theses mutants. Using the fluorescence resonance energy transfer
(FRET)-based luminal Ca2þ sensing protein, D1ER, we monitored the luminal
Ca2þ dynamics in HEK293 cells expressing RyR2 wt and mutants during Ca2þ
overload. Interestingly, we found that the G4871R mutation significantly low-
ered the critical luminal Ca2þ level at which Ca2þ release is terminated (the ter-
mination threshold), but it had no effect on the critical luminal Ca2þ level at
which spontaneous Ca2þ release or SOICR occurs (the SOICR threshold), as
compared with wt. In contrast, the I4862A mutation markedly lowered the
SOICR threshold with little impact on the termination threshold. On the other
hand, the Q4876A mutation lowered both the SOICR and termination thresh-
olds, whereas the E4872A mutation raised both thresholds. Taken together,
our data demonstrate that the pore region of RyR2 is an important determinant
of both activation and termination of Ca2þ release, and suggest that the path-
ways for Ca2þ release activation and termination are distinct but overlap.
1571-Pos
Modulation of Synchronous Gating in Skeletal Muscle Ryanodine
Receptor Channels (RyR1) by Nucleotides or Phosphorylation
Jake T. Neumann, Julio A. Copello.
Southern Illinois University School of Medicine, Springfield, IL, USA.
In skeletal muscle fibers, local Ca2þ sparks and global Ca2þ transients arise
from the synchronous activation of arrays of calcium release channels
(RyR1) in the sarcoplasmic reticulum. Marx et al. (1998) first described that
synchronous Ca2þ signaling in cells could be explained by the coordinated gat-
ing of neighboring RyR1 channels; i.e. ‘‘coupled gating’’. We have previously
reported that coupled gating of multiple RyR1 channels requires luminal Ca2þ
as current carrier and ATP/Mg2þ in the cytosolic solution. Here, we have re-
constituted into planar lipid bilayers multiple RyR1 channels from skeletal
muscle SR microsomes and determined their modulation by different nucleo-
tides. As found for ATP, we determined that ADP and AMP can activate
RyR1 and favor coupled gating. Contrarily, ITP, GTP and TTP did not affect
channel behavior. A priori, the ATP action seems more robust than that of
ADP/AMP (remains after addition of Mg2þ). Consequently, we tested the pos-
sibility of a phosphorylation-mediated mechanism to explain ATP efficacy.
However, we found that addition of PKA, CaMK or phosphatases did not sig-
nificantly affect channel activity. The lack of effects of kinases/phosphatases
was confirmed with macroscopic assays of SR Ca2þ release. Thus, our results
suggest that nucleotide modulation of RyR1 seems to be specific for adenine
nucleotides (especially ATP) and that RyR1 behavior in skeletal muscle does
not appear to be significantly modulated by phosphorylation. (Supported by
NIH R01 GM078665)
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Modification of Cardiac Ryanodine Receptors by Reactive Carbonyl
Species Alter Conductance and Gating
Shouqiang Ouyang1, Chengju Tian1, Chun-Hong Shao1, Wayne Chen2,
Keshore Bidasee1.
1University of Nebraska Med Ctr, Omaha, NE, USA, 2University of Calgary,
Calgary, AB, Canada.
Previously, we and others found that ventricular myocytes isolated from strep-
tozotocin (STZ)-induced diabetic rats exhibited enhanced spontaneous Ca2þ
releases. To date, molecular mechanisms underlying this phenomenon remains
incompletely understood. This study was designed to determine whether car-
bonyl adducts previously found on RyR2 during diabetes contribute to its dys-
regulation. Male Sprague-Dawley rats were injected with STZ. Six weeks later,
diabetic rats were divided into two groups: one group was treated with insulin
for two weeks while the other group received no treatment. Non-diabetic con-
trols were run alongside. After eight weeks, RyR2 was isolated and proteolipo-
somes prepared. Following incorporation into the lipid bilayer, diabetic RyR2,
which contained elevated levels of carbonyl adducts, activated to a greater
302a Monday, February 22, 2010extent with 1.0 mM Ca2þ than control RyR2 (Po was 5X greater in diabetic
RyR2). Two weeks of insulin treatment blunted the enhanced Ca2þ responsive-
ness. When added to the cis chamber the potent reactive carbonyl species
(RCS), 80 mM methylglyoxal increased the open probability (Po) of RyR2 3-
fold (0.05 to 0.16) within 10 min and this increase was independent of holding
potential. Increasing [MGO] further to 160 mM, reduced the conductance of
RyR2 by 25% without changing Po. Incubating RyR2 with MGO (5-500 mM
with 200 mM free Ca2þ in buffer) dose-dependently reduced its ability to bind-
ing [3H]ryanodine. Singly mutating R1611, R2190 and K2888 to W or Y, to
mimic adducts previously found on them during diabetes, resulted in gain-of-
function of RyR2 (Po increased >2-fold at 3.3 mM Ca
2þ ). Mutating c-terminal
R4462, and R4683 toW or Y resulted in loss-of function of RyR2.We conclude
that modification of RyR2 by RCS during diabetes is responsible in part for its
dysregulation. (This work was funded by NIH and Nebraska Redox Biology
Center)
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Gating of the Purified Human Cardiac Ryanodine Receptor (hRyR2) in the
Absence of Regulatory Accessory Proteins
Saptarshi Mukherjee, Nia Lowri Thomas, Laila Guzadhur,
Chloe E. Maxwell, Alan J. Williams.
Cardiff University, Cardiff, United Kingdom.
The cardiac ryanodine receptor (RyR2) mediates Ca2þ efflux from intracellular
stores to effect myocyte contraction during excitation-contraction coupling.
Mutations in this channel perturb Ca2þ release function, leading to triggered
arrhythmias that may cause sudden cardiac death (SCD). The exact molecular
mechanisms by which SCD-linked RyR2 dysfunction occurs constitutes a bur-
geoning area of cardiac research. Most studies so far have concentrated on the
secondary effects of mutation on channel function by virtue of affecting chan-
nel modification by phosphorylation and accessory protein binding, with no
great emphasis on elucidating the gating mechanisms of the channel itself.
Our aim is to elucidate the mechanistic basis of wild-type (WT) hRyR2 activa-
tion by its primary activating ligand, Ca2þ, under precisely controlled condi-
tions in the absence of any accessory proteins with a view to determining the
effect of mutation on hRyR2 gating in the same way. hRyR2 channels, recom-
binantly expressed in HEK293 cells, were purified and studied at the single
channel level in symmetrical 210mM KCl under reducing conditions. Trans
(luminal) Ca2þ was buffered at 50nM using EGTA, while cis (cytosolic)
Ca2þ buffering was stringently controlled using EGTA, HEDTA and NTA to
achieve free Ca2þ concentrations in the range of 0-500 mM. Preliminary data
obtained from sigmoidal dose-response curves of Po vs pCa for 10 WT
hRyR2 channels yields an EC50 of 3.2551.04 mM, resulting in a maximum
Po greater than 0.8 (in 5 out of 10 channels). This increase in Po resulted
from an increase in the frequency of channel openings, until Po of 0.8 - above
which any increases in Po resulted from an increase in open times. Likely gating
mechanisms will be discussed with a view to mutant channel analysis.
Supported by the British Heart Foundation
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S-Adenosyl-L-Methionine Activation of Cardiac Ryanodinr Receptors is
Associated with an Increased Frequency of Subconductance Sates
Angela J. Kampfer, Edward M. Balog.
Georgia Institute of Technology, Atlanta, GA, USA.
The biological methyl group donor, S-adenosyl-L-methionine (SAM) activates
the cardiac ryanodine receptor (RyR2). Previously we investigated the mecha-
nism underlying SAM regulation of RyR2 with [3H]ryanodine binding to car-
diac SR vesicles. SAM enhances Ca2þ -activation of RyR2 and increases the
apparent affinity of ryanodine for the channel. Notably, methyltransferase in-
hibitors have no effect on SAM-activation, and SAM-mediated methylation
of RyR2 is not detected. Furthermore, the concentration dependence for
SAM and ATP-induced increase in [3H]ryanodine binding overlap. Presently,
we investigated the affect of SAM on native RyR2 channels incorporated
into planar lipid bilayers. Channel were grouped according to initial Po values
under control conditions (10 mM cytosolic Ca2þ), those with Po < 0.2 (n=7),
and Po > 0.2 (n=5). For channels with an initial Po < 0.2, SAM caused a rapid
(within seconds) increase in Po (p< 0.05). The SAM-induced increase in Po was
due primarily to an increase in mean open time (p<0.05; n¼3). Interestingly,
SAM activation was associated with an increased frequency of subconduca-
tance states. In contrast, the increase in channel Po caused by 2mM ATP
was not associated with the appearance of subconductance states. Thus, the ef-
fect on subconductance states appears specific to SAM. This work highlights
the complexity underlying SAM regulation of RyR2. The data suggest ligand
binding is among the multiple mechanisms responsible for SAM-activation
of RyR2.1575-Pos
Molecular Interplay between the Heart Lim Protein (HLP) and RyR2 in
Murine Heart
Dong Woo Song, So Yeon Park, Do Han Kim.
Gwangju Institute Science and Technology, Gwangju, Korea, Republic of.
HLP is a heart-specific LIM-only protein having two LIM domains each con-
sisting of two zinc fingers. Through the bacterial 2 hybrid screening and a fol-
lowing LC-MS/MS study, we have found that HLP interacts with the cytosolic
divergent region of mouse heart RyR2. The direct interaction between RyR2
and HLP was confirmed by GST pull-down and co-immunoprecipitation as-
says. HLP was partially co-localized with RyR2 in HL-1 cells and rat adult car-
diomyocytes. siRNA or Adenovirus-mediated knock-down of HLP in HL-1
cells and neonatal cardiomyocytes led to more than 70% decrease in the expres-
sion of HLP, without a concomitant change of other Ca2þ handling proteins
(e.g. SERCA, RyR2, calsequestrin and DHPR). Ca2þ transient measurement
of fura2-loaded cardiomyocytes by 1Hz field stimulation demonstrated that si-
lencing of HLP decreased the peak amplitude of Ca2þ transient (~ 15%) in HL-
1 cells and in neonatal cardiomyocytes. Currently, various deletion-mutants of
LIM protein are being used to characterize the RyR2 binding sites in HLP.
(This work was supported by the Korean Ministry of Science and Technology
grant, Systems Biology Research Grant, M1050301001-6N0301-0110, and the
2009 GIST Systems Biology Infrastructure Establishment Grant).
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Mitsugumin-29 Regulates RyR1 Activity In Mouse Skeletal Myotubes
Ji-Hye Hwang, Jin Seok Woo, Eun Hui Lee.
The Catholic Univ. of Korea, Seoul, Republic of Korea.
Canonical-type transient receptor potential cation channel type 3 (TRPC3) in
plasma membrane allows the entry of Ca2þ ions into various cells. In skeletal
myotubes, functional interaction between TRPC3 and RyR1 (ryanodine recep-
tor1, a Ca2þ channel in sarcoplasmic reticulum (SR) membrane) regulates the
gain of skeletal excitation-contraction coupling (J. Biol. Chem., 2006). Mitsu-
gumin-29 (MG29) is a four membrane-spanning protein and is found in both
plasma and SR membrane. MG29 has been known as a TRPC3-interacting pro-
tein in skeletal myotubes (Biochem. J., 2008).
To identify critical region(s) of MG29 that participate in binding to TRPC3 or
the role of MG29 in skeletal muscle, N-terminus, three intervenient loops
among four transmembrane regions, and C-terminus of MG29 were expressed
in E. coil as N-terminal GST-fused forms, and subjected to co-immunoprecip-
itation assay with intact TRPC3 from rabbit skeletal muscle. Cytoplasmic N-
terminus and a loop between first and second transmembrane domains of
MG29 effectively bound to TRPC3. Two deletion mutants of MG29 (missing
the TRPC3-binding sites: deleting the N-terminus only or longer N-terminus
covering the loop region) was expressed in mouse skeletal myotubes, and the
myotubes was subjected to the measurement of Ca2þ transients with Fura-2
or Fluo-4. The later mutant showed significantly decreased responsiveness of
RyR1 to caffeine, suggesting that MG29 may be a mediator between the func-
tional interaction between TRPC3 and RyR1.
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Phosphorylation of Excitation-Contraction Coupling Components in
a Guinea-Pig Model of Heart Failure
Mark L. Bannister1, Mark Scoote2, Martyn P. Kingsbury1, Mark A. Turner1,
Jolanda van der Velden3, Desmond J. Sheridan1, Alan J. Williams4,
Sian E. Harding1.
1Imperial College, London, United Kingdom, 2Colchester Hospital
University, Colchester, United Kingdom, 3VU University Medical Centre,
Amsterdam, Netherlands, 4Wales Heart Research Institute, Cardiff, United
Kingdom.
Phosphorylation status appears to be a key determinant of excitation-contrac-
tion coupling ion channel and pump function. Dysfunction of the ryanodine re-
ceptor (RyR) secondary to catecholaminergic drive and phosphorylation has
been proposed as a factor in contractile dysfunction and arrhythmia patho-phys-
iology in the failing heart. The phosphorylation states of RyR, along with those
of phospholamban and troponin I have been investigated by immunoblotting,
and quantitated by comparing levels in failing hearts with basal levels, mini-
mum levels after beta-blocker treatment and maximal levels achieved by ex
vivo treatment with isoprenaline. We found that RyR residue Ser2809 was
phosphorylated to 124 5 11 % (n ¼ 5, P > 0.05) of control (sham-operated,
basal) in heart failure under basal conditions and 143 5 12 % (n ¼ 6, P <
0.05) with isoprenaline treatment, and residue Ser2030 was 94 5 10 % (n ¼
8, P > 0.05) for heart failure and 1995 9 % (n=6, P < 0.05) for isoprenaline
treatment. Phosphorylation levels at Ser16 of phospholamban were higher:
159 5 17 % (heart failure, n ¼ 7, P < 0.05) and 366 5 95 % (isoprenaline
treatment, n ¼ 5, P < 0.05). At Ser23/24 of troponin I there is no significant
